Cash transfers do not increase traumatic injury and mortality: evidence from Alaska - Top-Institutions - MDSpire

Cash transfers do not increase traumatic injury and mortality: evidence from Alaska

  • By

  • Ruby Steedle

  • Robert E M Pickett

  • Tasce Bongiovanni

  • Hailie Dono

  • Byungkyu Lee

  • Erica Hobby

  • Anne Zink

  • Sarah K Cowan

  • January 29, 2026

  • 0 min

Share

Top Institutions in Emergency Medicine

Brief introduction explaining scope and methodology.

  • #1

    Harvard T.H. Chan School of Public Health
    Harvard T.H. Chan School of Public Health

    Boston, MA

    Key Differentiators

    • Epidemiology
    • Public Health
    • Health Policy

  • #2

    Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public Health

    Baltimore, MD

    Key Differentiators

    • Epidemiology
    • Injury Prevention
    • Health Policy

  • #3

    University of California, Berkeley School of Public Health
    University of California, Berkeley School of Public Health

    Berkeley, CA

    Key Differentiators

    • Epidemiology
    • Health Economics
    • Social Epidemiology

  • #4

    University of Washington School of Public Health
    University of Washington School of Public Health

    Seattle, WA

    Key Differentiators

    • Epidemiology
    • Injury Prevention
    • Health Policy

Original Source(s)

Cash transfers do not increase traumatic injury and mortality: evidence from Alaska

  • by Ruby Steedle, Robert E M Pickett, Tasce Bongiovanni, Hailie Dono, Byungkyu Lee, Erica Hobby, Anne Zink, Sarah K Cowan

  • January 29, 2026

Related Content

Impact of Cannabis Edibles Combined With Alcohol on Driving, Field Sobriety Performance, and Subjective

Ophthalmology’s Role in the Opioid Crisis

Retrospective cohort study investigates how ophthalmologists can provide potentially life-saving care to substance use disorder patients

Global emergence and γ-aminobutyric acid type A (GABAA) receptor activity of the new designer benzodiazepine ethylbromazolam